Kedalion Therapeutics is a clinical-stage, venture-funded ophthalmic drug company based in Menlo Park, CA. Kedalion's AcuStream technology delivers topical drugs to the eye in a precise and accurate manner that enables comparable efficacy with an 80% reduction in dose compared to standard drops, and a significantly improved side effect profile along with patient comfort and convenience following self-administration.

Biotechnology

Kedalion Therapeutics

Mark Blumenkranz

Mark Murray

Ehud Ivri

Casey Dougan

Joseph Gilbert

Reynaldo Quintana

The Strategic Advisory Team at Kedalion Therapeutics provides high-level guidance and strategic insights to support the company's mission of revolutionizing ophthalmic drug delivery with its AcuStream technology. The team collaborates on long-term planning, market positioning, and partnerships to optimize clinical outcomes and maximize business growth.

Strategic Advisory Team

Scientific Team

Leadership Team

Strategic Advisory Team

About

Team members

Other teams at Kedalion Therapeutics

Scientific Team

Leadership Team